What does legacy reinsurance — other assets mean?

Miscellaneous assets held by the Legacy Reinsurance segment that do not fall into primary categories like cash, receivables, or investments. This captures residual asset value and provides a complete view of the segment's balance sheet composition.

King Pharmaceuticals KG Legacy Reinsurance — Other assets

Similar metrics at other companies

CRBGLegacy Life And Retirement Run Off Lines Segment Member — Reinsurance assets

$24.1B-3.2%

RWTLegacy Investments — Total Assets

$945.02M-69.4%

RWTLegacy Investments — Other Expenses

$0—

EGLegacy — Other underwriting expenses

$65M-36.9%

RWTLegacy Investments — Other income, net

$950K—

EQHGross Legacy — Other (4)

$1M-97.0%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherAssets.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — other assets?: King Pharmaceuticals (KG) reported legacy reinsurance — other assets of $603K in Q1 2026.
What does legacy reinsurance — other assets mean?: Miscellaneous assets held by the Legacy Reinsurance segment that do not fall into primary categories like cash, receivables, or investments. This captures residual asset value and provides a complete view of the segment's balance sheet composition.